Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ADN | Common Stock | 379K | Jul 20, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ADN | Employee Stock Options (right to buy) | Jul 20, 2022 | Common Stock | 175K | $2.74 | Direct | F2, F3 | ||||||
holding | ADN | Employee Stock Options (right to buy) | Jul 20, 2022 | Common Stock | 75K | $7.40 | Direct | F2, F4 |
Id | Content |
---|---|
F1 | Includes 175,000 restricted stock units ("RSUs") granted July 12, 2022, and 75,000 RSUs granted August 31, 2021, each representing a contingent right to receive common stock. Such RSUs were granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan"). RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. They vest 25% on each anniversary of their grant date over four years. |
F2 | Employee stock options (right to buy) ("Options") granted pursuant to the Plan. |
F3 | Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of July 12, 2026. |
F4 | Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of August 31, 2025. |